Evidence map›Paper›PMID 22944304›Full record

ReviewInternational journal of pharmaceutics2013

Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.

Ying Lu, Kinam Park

Abstract readReview
In one paragraph

Review in International journal of pharmaceutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ying LuPurdue University, School of Pharmacy, West Lafayette, IN 47906, USA.
Kinam Park

Funding

Hydrotropic Polymers for oral delivery of paclitaxelR01GM065284 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI PARK, KINAM · 2002 to 2008
$1.6M
Adaptable Polymer Micelles for Tumor TargetingR01CA129287 · NCI · PURDUE UNIVERSITY · PI PARK, KINAM · 2010 to 2014
$1.5M
Hydrogel template method for protein microencapsulationR01GM095879 · NIGMS · PURDUE UNIVERSITY · PI PARK, KINAM · 2012 to 2015
$1.1M
NCI NIH HHS CA129287NCI NIH HHS R01 CA129287NIGMS NIH HHS GM095879NIGMS NIH HHS R01 GM065284NIGMS NIH HHS R01 GM095879
6 · The paper itself

Abstract

Poorly soluble drugs often encounter low bioavailability and erratic absorption patterns in the clinical setting. Due to the rising number of compounds having solubility issues, finding ways to enhance the solubility of drugs is one of the major challenges in the pharmaceutical industry today. Polymeric micelles, which form upon self-assembly of amphiphilic macromolecules, can act as solubilizing agents for delivery of poorly soluble drugs. This manuscript examines the fundamentals of polymeric micelles through reviews of representative literature and demonstrates possible applications through recent examples of clinical trial developments. In particular, the potential of polymeric micelles for delivery of poorly water-soluble drugs, especially in the areas of oral delivery and in cancer therapy, is discussed. Key considerations in utilizing polymeric micelles' advantages and overcoming potential disadvantages have been highlighted. Lastly, other possible strategies related to particle size reduction for enhancing solubilization of poorly water-soluble drugs are introduced.

Indexed as

Drug Delivery SystemsMicellesAdministration, OralAnimalsAntineoplastic AgentsHumansNanostructuresNeoplasmsPolymersSolubilityAntineoplastic AgentsMicellesPolymersAnticancerClinical trialDrug solubilizationMicelle stabilityNanocrystalNanoemulsionOral deliveryPolymeric micelle

Identifiers

PMID22944304
PMCPMC3760723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.